Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2010

Nov 15, 2010

30071_dirs_2010-11-15_1058f1d8-7866-4c25-ae9b-79b258eb1d8f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-11-11

Reporting Person: PENDARVIS DAVID (Sr. VP, General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-11-11 ResMed Common Stock F 2227 $33.70 Disposed 25725.12 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-11-11 ResMed Common Stock Options $33.70 A 75000 Acquired 2017-11-11 ResMed Common Stock (75000) Direct

Footnotes

F1: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 12/17/2009 and vesting 11/11/2010.

F2: Includes 358.017 shares purchased on October 30, 2010, pursuant to ResMed's Employee Stock Purchase Plan.

F3: Represents first date 1/4 of the options become exercisable. Thereafter, options will continue to vest 1/4 annually until fully vested.